250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre studyPaul O’Connor, Timon Bogumil, Massimo Filippi et al.|The Lancet Neurology|2009Cited by 403
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1bKathryn C. Fitzgerald, Alberto Ascherio, Kassandra L. Munger et al.|JAMA Neurology|2015Cited by 169
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysisStuart D. Cook, Elke Sylvester, Christine Hicking et al.|Multiple Sclerosis and Related Disorders|2018Cited by 122